Sanskar Ranglani (Sibah Hasan)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Angiotensin Converting Enzyme

Papillary Thyroid

Mild Cognitive Impairment

Cross Sectional

Top Venues

International journal of molecular sciences

Diabetes, obesity & metabolism

Molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Sanskar Ranglani, Sanskar Ranglani, Joanna Komorowska, Nathalia Mayag Medina, Kashif Mahfooz, Anna Ashton, Sara Garcia-Ratés, Susan Greenfield
A Novel Peptide Driving Neurodegeneration Appears Exclusively Linked to the α7 Nicotinic Acetylcholine Receptor. Molecular neurobiology (2024)
Sanskar Ranglani, Anna Ashton, Kashif Mahfooz, Joanna Komorowska, Alexandru Graur, Nadine Kabbani, Sara Garcia-Ratés, Susan Greenfield
A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive Applications. International journal of molecular sciences 24 (12) (2023)
Sanskar Ranglani, Anna Ashton, Kashif Mahfooz, Joanna Komorowska, Alexandru Graur, Nadine Kabbani, Sara Garcia-Ratés, Susan Greenfield
A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive Applications. International journal of molecular sciences 24 (12) (2023)
Sanskar Ranglani, Joey Ward, Naveed Sattar, Rona J Strawbridge, Donald M Lyall
Testing for associations between HbA1c levels, polygenic risk and brain health in UK Biobank (N = 39 283). Diabetes, obesity & metabolism (2023)
Sanskar Ranglani, Anna Ashton, Kashif Mahfooz, Joanna Komorowska, Alexandru Graur, Nadine Kabbani, Sara Garcia-Ratés, Susan Greenfield
A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive Applications. International journal of molecular sciences 24 (12) (2023)